| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $560.2M | +29.0% |
| R&D Expense | $697.9M | +7.6% |
| SG&A Expense | $321.6M | +3.8% |
| Operating Income | -$536.0M | +5.8% |
| Pre-tax Income | -$567.6M | +6.7% |
| Income Tax | $1.6M | +187.5% |
| Net Income | -$569.2M | +6.2% |
| EPS (Basic) | -$6.29 | +23.8% |
| EPS (Diluted) | -$6.29 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $173.7M | -18.7% |
| Accounts Receivable | $121.8M | +66.0% |
| Inventory | $45.0M | +32.5% |
| Current Assets | $817.1M | +11.6% |
| Total Assets | $1.50B | +0.8% |
| Current Liabilities | $344.2M | +22.7% |
| Total Liabilities | $1.24B | +2.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$414.2M | +12.8% |
| Capital Expenditures | $7.5M | -83.1% |
| Investing Cash Flow | -$17.8M | -110.6% |
| Financing Cash Flow | $399.2M | +2.9% |
| Free Cash Flow | -$421.7M | +18.8% |
| +23.8% |
| Stockholders' Equity |
| $255.3M |
| -7.3% |